Ranbaxy gets US FDA nod for loratadine tab
By siliconindia
|
Wednesday, 20 August 2003, 19:30 IST
NEW DELHI: Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to market a generic version of Schering-Plough Corp's anti-allergy Claritin tablets in the 10mg strength, says FDA site www.fda.gov showed.
Ranbaxy had earlier got a tentative nod for the 10 mg loratadine tablets in December 2001. The drug's patent expired last year and it is being sold in the over-the-counter market in the United States by several generic firms, besides the innovator Schering.
Claritin, once a blockbuster drug in Schering's stable, had US sales of $944 million in the 12 months ended June 2003.